One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design
Julie C. Lauffenburger, PharmD, PhD, a,b , Rasha Khatib, MHS, PhD, c , Alvia Siddiqi, MD, d , Michelle A. Albert, MD, MPH, e , Punam A. Keller, PhD, f , Lipika Samal, MD, MPH, g , Nicole Glowacki, MPH, c , Marlon E. Everett, MD, h , Kaitlin Hanken, MPH, a,b , Simin G. Lee, MD, MBA, a,b , Gauri Bhatkhande, MPH, a,b , Nancy Haff, MD, MPH, a,b , Ellen S. Sears, BS, a,b , and Niteesh K. Choudhry, MD, PhD a,b Boston, MA; Downers Grove, IL; San Francisco, CA; Hanover, NH; Chicago, IL
doi : 10.1016/j.ahj.2022.10.003
Volume 255, January 2023, Pages 12-21
While racial/ethnic disparities in blood pressure control are documented, few interventions have successfully reduced these gaps.
Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation – the third nordic aortic valve intervention trial – NOTION-3
Muhammad Sabbah, MD a , Karsten Veien, MD b , Matti Niemela, MD c , Phillip Freeman, MD, PhD d , Rickard Linder, MD, PhD, FESC e,f , Dan Ioanes, MD g , Christian Juhl Terkelsen, MD, DMSc h,i , Olli A. Kajander, MD, PhD j , Sasha Koul, MD k , Mikko Savontaus, MD l , Pasi Karjalainen, MD, PhD j , Andrejs Erglis, MD m , Mikko Minkkinen, MD j , Troels Jørgensen, MD, PhD a , Lars Sondergaard, MD, PhD, DMSc a,n , Ole De Backer, MD, PhD a , Thomas Engstrøm, MD, PhD, DMSc a,n , and Jacob Lønborg, MD, PhD, DMSc a Denmark; Finland; Sweden
doi : 10.1016/j.ahj.2022.10.009
Volume 255, January 2023, Pages 39-51
The patient-reported outcome measurement in heart failure clinic trial: Rationale and methods of the PRO-HF trial
Neil M. Kalwani, MD, MPP a,b , Jamie Calma, BA a , George M. Varghese, MBBS a , Anshal Gupta, MTM c , Jimmy Zheng, BS c , Cati Brown-Johnson, PhD d , Alexis Amano, MS d , Stacie Vilendrer, MD, MBA, MS d , Marcy Winget, PhD d , Steven M. Asch, MD MPH b,d , Paul Heidenreich, MD, MS a,b , and Alexander Sandhu, MD, MS a,b Stanford, CA; Palo Alto, CA; Stanford, CA
doi : 10.1016/j.ahj.2022.10.081
Volume 255, January 2023, Pages 137-146
Danish-German cardiogenic shock trial—DanGer shock: Trial design update
Jacob Eifer Møller, MD, PhD, DMSc a,b,c , and Oke Gerke, PhD b,d , on behalf of DanGer Shock Investigators# Odense, Denmark; Copenhagen, Denmark
doi : 10.1016/j.ahj.2022.10.078
Volume 255, January 2023, Pages 90-93
The main objective of the Danish German Cardiogenic Shock trial (DanGer Shock ClinicalTrials.gov Identifier: NCT01633502) is to assess the efficacy of the trans valvular axial flow device Impella CP in treating patients with AMICS shock due to STEMI undergoing emergency percutaneous coronary intervention.
Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data
Konstantinos S. Mylonas, MD a,# , Panagiotis T. Tasoudis, MS b,# , Dionysios Pavlopoulos, MD, PhD a , Meletios Kanakis, MD, PhD c , George T. Stavridis, MD, FETCS a , and Dimitrios V. Avgerinos, MD, PhD, FACS, FACC a Athens, Greece; Biopolis, Greece; Athens, Greece;
doi : 10.1016/j.ahj.2022.09.003
Volume 255, January 2023, Pages 1-11
Aortic valve neocuspidization using the Ozaki technique has shown promising results both in adults and children.
Laennecs’ mediate auscultation: Child's play
Emmanuel Drouin, PhD a , Arnaud Chambellan, MD, PhD b , and Patrick Hautecoeur, MD a Lille, France
doi : 10.1016/j.ahj.2022.10.076
Volume 255, January 2023, Pages 52-57
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta
Alexander C. Egbe, MDMPH,, William R. Miranda, MD, Christopher Charles Jain, MD, and Heidi M. Connolly, MD Rochester, MN;
doi : 10.1016/j.ahj.2022.10.008
Volume 255, January 2023, Pages 22-30
Infarct-related artery and long-term mortality following recurrent ST-segment elevation myocardial infarction. Insights from a Polish nationwide registry
Rafał Wolny, MD, PhD a , Jacek Niedziela, MD, PhD b , Piotr Desperak, MD, PhD b , Jacek Kwieci �nski, MD, PhD a , Maksymilian P. Opolski, Prof. a , Mariusz G ̨asior, Prof. b , and Adam Witkowski, Prof. a Warsaw, Mazowieckie; Katowice, Silesian
doi : 10.1016/j.ahj.2022.10.004
Volume 255, January 2023, Pages 31-38
Diagnostic discrimination of a novel high-sensitivity cardiac troponin I assay and derivation/validation of an assay-specific 0/1h-algorithm
Luca Koechlin, MD a,b,c,1,∗, Jasper Boeddinghaus, MD a,c,d,e,1 , Pedro Lopez-Ayala, MD a,c , Thomas Nestelberger, MD a,c,f , Desiree Wussler, MD a,c,d , Felix Mais a,g , Raphael Twerenbold, MD, Professor a,h , Tobias Zimmermann, MD a,c , Karin Wildi, MD a,c,i , Anne Marie Köppen a , Òscar Miró, MD c,j , F. Javier Martin-Sanchez, MD c,k , Damian Kawecki, MD c,l , Nicolas Geigy, MD m , Dagmar I. Keller, MD, Professor g , Michael Christ, MD, Professor n , Andreas Buser, MD, Professor o , Maria Rubini Giménez, MD a,p , Luca Bernasconi, Dr. sc. nat. q , Angelika Hammerer-Lercher, MD q , and Christian Mueller, MD a,c,∗, for the APACE investigators# Basel, Switzerland; Edinburgh, Scotland; British Columbia, Canada; Zurich, Switzerland; Hamburg, Germany; Queensland, Australia; Catalonia, Spain; Madrid, Spain; Silesian, Poland; Liestal, Switzerland; Saxony, Germany; Aarau, Switzerland; Moravia, Czech Republic
doi : 10.1016/j.ahj.2022.10.007
Volume 255, January 2023, Pages 58-70
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials
Angelo Oliva, MD a,b , Domenico S. Castiello, MD c , Anna Franzone, MD, PhD c , Gianluigi Condorelli, MD, PhD a,b , Antonio Colombo, MD a,b , Giovanni Esposito, MD, PhD c , Giulio G. Stefanini, MD, PhD a,b , and Raffaele Piccolo, MD, PhD c Pieve Emanuele, Milan; Rozzano, Milan
doi : 10.1016/j.ahj.2022.10.006
Volume 255, January 2023, Pages 71-81
Monotherapy with P2Y12 inhibitors (P2Y12i) is emerging as alternative strategy to dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). However, early withdrawal of aspirin as part of P2Y12i monotherapy regimens may pose concerns in high-risk patients, such as those undergoing complex PCI.
Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial
Ole Fröbert, MD a , Matthias Götberg, MD b , David Erlinge, MD b , Zubair Akhtar, MPH c,e , Evald H. Christiansen, MD d , Chandini R. MacIntyre, MBBS, PhD e , Keith G. Oldroyd, MBChB, MD f , Zuzana Motovska, MD g , Andrejs Erglis, MD h , Rasmus Moer, MD i , Ota Hlinomaz, MD j , Lars Jakobsen, MD d , Thomas Engstrøm, MD k , Lisette O. Jensen, MD l , Christian O. Fallesen, MD l , Svend E Jensen, MD m , Oskar Angerås, MD n , Fredrik Calais, MD a , Amra Kåregren, MD o , Jörg Lauermann, MD p , Arash Mokhtari, MD b , Johan Nilsson, MD q , Jonas Persson, MD r , Per Stalby, MD s , Abu K.M.M. Islam, MD t , Afzalur Rahman, MD t , Fazila Malik, MBBS u , Sohel Choudhury, PhD u , Timothy Collier, MSc v , Stuart J. Pocock, PhD v , and John Pernow, MD w Orebro, Sweden; Scania, Sweden; Dhaka, Bangladesh; Aarhus, Denmark; New South Wales, Australia; Scotland, United Kingdom; Bohemia, Czech Republic; Riga, Latvia; Ostiandet, Norway; South Moravian, Czech Republic; Copenhagen, Denmark; Odense, Denmark; Kommune, Denmark; Vastergotland, Sweden; Ostergotland, Sweden; Vasterbotten lan, Sweden; Sodermanland and Uppland, Sweden; Dhaka, Bangladesh; London, United Kingdom; Stockholm, Sweden
doi : 10.1016/j.ahj.2022.10.005
Volume 255, January 2023, Pages 82-89
A comprehensive and easy-to-use ECG algorithm to predict the coronary occlusion site in ST-segment elevation myocardial infarction
Carlo Gaspardone, MD a,∗, Davide Romagnolo, MD a,∗, Alessandro Fasolino, MD b , Giulio Falasconi, MD a , Alessandro Beneduce, MD c , Giorgio Fiore, MD a , Emma Didelon, MSc a , Fabrizio Fortunato, MD d , Carmine Galdieri, MD a , Giuseppe Antonio Posteraro, MD e , Giacomo Ingallina, MD f , Francesco Ancona, MD f , Federico Biondi, MD f , Silvana Di Maio, MD a , Alice Casiraghi, MD a , Massimo Slavich, MD g , Giorgia Borio, MD a , Simone Savastano, MD h , Sergio Leonardi, MD b , Alberto Margonato, MD a,g , Eustachio Agricola, MD a,f , Michele Oppizzi, MD g , Achille Gaspardone, MD, MPhil e , Carlo Pappone, MD, PhD a,i , and Matteo Montorfano, MD a,c Milan, Italy; Pavia, Italy; Milan, Italy; Palermo, Italy; Rome, Italy; Milan, Italy; Milan, Italy; Milan, Italy
doi : 10.1016/j.ahj.2022.10.077
Volume 255, January 2023, Pages 94-105
Several electrocardiogram (ECG) criteria have been proposed to predict the location of the culprit occlusion in specific subsets of patients presenting with ST-segment elevation myocardial infarction (STEMI).
Race and outcomes after percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
Stephanie M Spehar, MD a , Milan Seth, MS b , Peter Henke, MD c , Khaldoon Alaswad, MD d , Theodore Schreiber, MD e , Aaron Berman, MD f , John Syrjamaki, MPH g , Omar E. Ali, MD h , Yousef Bader, MD i , David Nerenz, PhD j , Hitinder Gurm, MD b , and Devraj Sukul, MD, MSc b Ann Arbor, MI; Detroit, MI; Warren, MI; Royal Oak, MI; Bay City, MI
doi : 10.1016/j.ahj.2022.10.001
Volume 255, January 2023, Pages 106-116
Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry
Adam J Nelson, MBBS, MBA, MPH, PhD a,b , Taku Inohara, MD, PhD a,b , Sunil V. Rao, MD a,b , Lisa A. Kaltenbach, MS a,b , Daniel Wojdyla, PhD a,b , and Tracy Y. Wang, MD, MHS, MSc a,b Durham, NC
doi : 10.1016/j.ahj.2022.10.002
Volume 255, January 2023, Pages 117-124
Days at home after transcatheter or surgical aortic valve replacement in high-risk patients
Mabel Chung, MD, MPH a,b , Neel M. Butala, MD, MBA c , Kamil F. Faridi, MD, MSc d , Zaid I. Almarzooq, MD b,e , Dingning Liu, MA f , Jiaman Xu, MPH b,g , Yang Song, MS b,g , Suzanne J. Baron, MD, MSc b,h , Changyu Shen, PhD b,i , Dhruv S. Kazi, MD, MSc, MS b,g , and Robert W. Yeh, MD, MSc b,g Boston, MA; Aurora, CO; New Haven, CT; Burlington, MA; Cambridge, MA
doi : 10.1016/j.ahj.2022.10.080
Volume 255, January 2023, Pages 125-136
